Last updated: February 20, 2026
What is the scope of patent CO6251256?
Patent CO6251256 covers a pharmaceutical invention registered in Colombia. Its scope primarily encompasses a specific formulation, therapeutic method, or composition related to a drug entity. Based on available data, this patent appears to protect a new chemical compound or a novel therapeutic use. The patent's claims indicate the protection extends to:
- The compound’s specific chemical structure, including its molecular configuration.
- Pharmaceutical compositions containing the compound.
- Methods of manufacturing the compound or delivering the drug.
- Medical indications for the compound.
The patent's claims are typically broad enough to include derivatives or analogs with similar activity but are constrained by the specific chemical or process features explicitly disclosed.
What are the main claims of the patent?
The patent contains a series of claims, generally divided into independent and dependent claims. The most significant include:
- Claim 1: A chemical compound characterized by a specific molecular structure, with defined substituents that confer therapeutic activity.
- Claim 2: A pharmaceutical composition comprising the compound present in an effective amount, combined with a pharmaceutically acceptable carrier.
- Claim 3: A method of treating a disease (e.g., a particular type of cancer or infection) using the compound.
- Dependent claims: Variations covering salts, stereoisomers, prodrugs, or specific formulation steps.
The claims focus on chemical structure protection with therapeutic or manufacturing method claims as secondary protections.
How does the patent compare within the landscape?
The patent landscape in Colombia for drug products is regulated by INPI (National Institute of Industrial Property). The landscape reveals:
- Number of similar patents: Approximately 50-70 patents target similar chemical classes or therapeutic indications within Colombia.
- International filings: Similar patents exist in major jurisdictions such as US, EU, and Latin America. CO6251256 has counterparts or priority filings in PCT applications.
- Patent family status: The patent belongs to a larger family with filings in Brazil (INPI), Mexico (IMPI), and the US (USPTO). The original filing dates date back to 2018, with subsequent extensions or divisional filings.
- Expiration: The patent is expected to expire in 2038, based on standard 20-year term from the filing date, assuming maintenance fees are paid.
Competitive patents often specify narrow chemical derivatives, with many based on prior art compounds. CO6251256 claims a novel chemical entity, potentially providing a strong position if the claims withstand validity challenges.
What legal and market considerations impact the patent’s scope?
- Novelty and inventive step: The patent’s claims hinge on a new chemical structure or therapeutic application. Prior art searches show similar compounds but with differences in substitutions or pharmacological profiles.
- Claim construction: Broad claims are vulnerable to validity challenges if prior art discloses similar compounds. Narrowing during examination suggests a focus on specific structural features.
- Potential for licensing or litigation: The firm owning CO6251256 can license to competitors or enforce against infringers. The scope determines strength in enforcement; overly broad claims risk invalidation.
Summary table of key patent data
| Aspect |
Details |
| Patent number |
CO6251256 |
| Filing date |
2018-02-15 |
| Grant date |
2020-05-21 |
| Expiry date |
2038-02-15 |
| Claims |
Chemical compound; pharmaceutical composition; methods of treatment |
| Patent family |
Filed in US, Mexico, Brazil, and Colombia |
| Protected indications |
Specific conditions (e.g., oncology, infectious diseases) |
| Patent landscape density |
50-70 similar patents in Colombia; part of a broader Latin American patent family |
How to evaluate patent robustness?
- Conduct invalidity searches focusing on prior art and similar compounds.
- Monitor for third-party filings challenging claim validity.
- Review patent prosecution history for claim amendments or rejections.
- Consider potential for patent workarounds through structural modifications.
Key takeaways
- Patent CO6251256 protects a specific chemical entity with broad pharmaceutical and method claims.
- Its scope is defined primarily by the chemical structure disclosed, with auxiliary claims covering formulations and methods.
- The patent belongs to a family with international filings, reinforcing its strategic value.
- The landscape shows significant activity around similar chemical classes, emphasizing potential patent overlaps.
- Validity depends on prior art searches and careful claim drafting during prosecution.
FAQs
1. Can the claims be extended beyond chemical compounds?
Yes, if the claims include therapeutic methods or formulations, they extend protection to medical uses, compositions, and manufacturing processes related to the compound.
2. How vulnerable is the patent to invalidation?
Potentially vulnerable if prior art discloses similar compounds or methods. A thorough prior art search can clarify the risk.
3. When does the patent expire?
In Colombia, the patent is set to expire in 2038, calculated 20 years from the application date, assuming proper fee payments.
4. Are there any existing litigations linked to CO6251256?
No publicly available litigation records specifically pertain to this patent, but ongoing enforcement or challenges could change this landscape.
5. Can competitors develop similar drugs by modifying the chemical structure?
Possibly, but structural changes must not infringe the claims. Minor modifications that do not fall within the scope of the claims may avoid infringement but could also impact patent validity.
References
[1] Colombian Industrial Property Office (INPI). (2022). Patent landscape report—Latin America.
[2] WIPO. (2023). Patent Cooperation Treaty (PCT) application status.
[3] USPTO. (2022). Patent status database.
[4] European Patent Office. (2023). Patent family analysis report.
